{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:34:36Z","timestamp":1712190876643},"reference-count":14,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/ijn.ijn_257_21","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T17:20:53Z","timestamp":1653067253000},"page":"484","source":"Crossref","is-referenced-by-count":1,"title":["Myoglobinuria-induced acute kidney injury secondary to Covishield<sup>TM<\/sup> vaccination"],"prefix":"10.25259","volume":"32","author":[{"given":"Swarnalata","family":"Gowrishankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.345777-1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Oxford COVID vaccine trial group.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"key-10.4103\/0971-4065.345777-2","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.345777-3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.345777-4","doi-asserted-by":"crossref","first-page":"653786","DOI":"10.3389\/fimmu.2021.653786","article-title":"Acute transverse myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222)","author":"Rom\u00e1n","year":"2021","journal-title":"Front Immunol"},{"key":"key-10.4103\/0971-4065.345777-5","first-page":"143","article-title":"Types of acute phase reactants and their importance in vaccination","author":"Khalil","year":"2020","journal-title":"Biomed Rep"},{"key":"key-10.4103\/0971-4065.345777-6","first-page":"1","article-title":"Vaccination and autoimmunity-'vaccinosis': A dangerous liaison?","author":"Shoenfeld","year":"2000","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0971-4065.345777-7","unstructured":"United States Department of Health and Human Services (DHHS), Public Health Service (OHS), Centers for Disease Control (CDC), Vaccine Adverse Effects Reporting System (VAERS) 1990-5\/16\/2021, CDC WONDER On-line Database (2021). https\/\/wonders.cdc.gov\/vaers"},{"key":"key-10.4103\/0971-4065.345777-8","doi-asserted-by":"crossref","unstructured":"Tan A, Stepien KM, Narayana ST. Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis. QJM 2021;hcab077. doi: 10.1093\/qjmed\/hcab077. Online ahead of print.","DOI":"10.1093\/qjmed\/hcab077"},{"key":"key-10.4103\/0971-4065.345777-9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tmaid.2012.11.004","article-title":"Rhabdomyolysis secondary to influenza A H1N1 vaccine resulting in acute kidney injury","author":"Callado","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"key-10.4103\/0971-4065.345777-10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/20009666.2020.1841878","article-title":"Rhabdomyolysis after recombinant zoster vaccination: A rare adverse reaction","author":"Rajaratnam","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"key-10.4103\/0971-4065.345777-11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/1319-2442.270254","article-title":"Vaccine-associated kidney diseases: A narrative review of the literature","author":"Patel","year":"2019","journal-title":"Saudi J Kidney Dis Transpl","ISSN":"http:\/\/id.crossref.org\/issn\/1319-2442","issn-type":"print"},{"key":"key-10.4103\/0971-4065.345777-12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine","author":"Lebedev","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.345777-13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.kint.2021.05.001","article-title":"Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination","author":"Ayd\u0131n","year":"2021","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.345777-14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.kint.2021.03.002","article-title":"Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy","author":"Negrea","year":"2021","journal-title":"Kidney Int"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:46:10Z","timestamp":1712173570000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/myoglobinuria-induced-acute-kidney-injury-secondary-to-covishieldtm-vaccination\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"alternative-id":["345777"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_257_21","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}